Growth Metrics

IR-Med (IRME) Operating Leases (2022 - 2025)

IR-Med recorded quarterly Operating Leases of $26000.0 in Q2 2025, down 33.33% quarter-over-quarter from $39000.0 in Q4 2023.

IR-Med's Operating Leases history runs 3 years deep, the most recent figure standing at $26000.0 for Q2 2025.

  • In Q2 2025, Operating Leases changed N/A year-over-year to $26000.0; the TTM figure through Jun 2025 stood at $26000.0 (changed N/A YoY), while the FY2023 annual figure was $39000.0, down 2.5% from the prior year.
  • Operating Leases came in at $26000.0 for Q2 2025 at IR-Med, down from $39000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $40000.0 in Q4 2022 to a low of $2000.0 in Q3 2023.
  • A 3-year average of $26750.0 and a median of $32500.0 in 2023 frame the typical range for Operating Leases.
  • On a YoY basis, Operating Leases climbed as much as 2.5% in 2023 and fell as far as 2.5% in 2023.
  • IR-Med's Operating Leases stood at $40000.0 in 2022, then fell by 2.5% to $39000.0 in 2023, then tumbled by 33.33% to $26000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods registered $26000.0, $39000.0, and $2000.0 for Q2 2025, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 IR-Med - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 26,000.00
Dec 31, 2023 39,000.00
Sep 30, 2023 2,000.00
Dec 31, 2022 40,000.00